HIV-1 neutralizing antibodies: understanding nature's pathways
about
HIV-Host Interactions: Implications for Vaccine DesignRecent update in HIV vaccine developmentThe Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C VirusAnergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged PathogensA New Scientific Paradigm may be Needed to Finally Develop an HIV VaccineDesigning synthetic vaccines for HIVAntibody responses to envelope glycoproteins in HIV-1 infectionSerology in the 21st century: the molecular-level analysis of the serum antibody repertoireRelated Mechanisms of Antibody Somatic Hypermutation and Class Switch RecombinationCD169-dependent cell-associated HIV-1 transmission: a driver of virus disseminationDevelopment of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infectionVirological features associated with the development of broadly neutralizing antibodies to HIV-1Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesMaturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyDevelopmental pathway for potent V1V2-directed HIV-neutralizing antibodiesStructural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesignAntibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope SpikeProgress in HIV-1 vaccine development.Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological TheoryHIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physiciansAntibody potency relates to the ability to recognize the closed, pre-fusion form of HIV EnvCross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env GeneHIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmissionHumanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity.Current views on the potential for development of a HIV vaccine.Lessons learned from human HIV vaccine trials.HIV-1 vaccines: challenges and new perspectivesBroadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune SystemBroad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals.Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesPrecision immunomedicineWhich Antibody Functions are Important for an HIV Vaccine?A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus.Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralizationHIV-1 envelope proteins and V1/V2 domain scaffolds with mannose-5 to improve the magnitude and quality of protective antibody responses to HIV-1Why HIV virions have low numbers of envelope spikes: implications for vaccine development.Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination.Neutralizing antibodies inhibit HIV-1 infection of plasmacytoid dendritic cells by an FcγRIIa independent mechanism and do not diminish cytokines production.
P2860
Q26765966-4DFF769E-F16C-4082-816F-D054D248F10BQ26766628-992FBED2-88D8-424C-8AFF-D7366EDE7CF7Q26767258-F3072CCC-BE87-48B7-A99E-BBA07EF83779Q26774672-00955AF2-70ED-4736-9C12-F7845E941131Q26830360-5C52E8AD-DBD9-4306-8A94-7632EFB3DEC3Q26862617-7BA7258B-9BA1-4275-95B7-935D119540FEQ26991572-A6B060C9-8290-4ACE-8C48-7D05FAF7D2ACQ26997997-ECC4A1A6-8CF7-4358-811C-054176ACC014Q27000758-22EE1664-C791-46B1-9A94-017CB88189C2Q27008186-8C11D508-298E-4048-894B-FE5112184B53Q27022652-50371F64-4940-4A0B-BB3D-0D0C56B40FD0Q27025177-ADE619D1-8952-42E6-9E04-653565EA6E4BQ27318508-A92AF0FB-B0E7-4641-B4BF-BB6F465E549EQ27644415-A39A67F8-EF9C-4DC8-A9B4-E02DCA3EEE70Q27644515-49FE8EDA-BF44-4C0A-B63E-D6E6138189DFQ27680810-C53347B6-636E-494D-AA8F-E0E0A72E2414Q27681806-97142E3E-2D85-445F-9893-04C844295024Q27683540-BD38C73B-3204-4655-9B39-E6E651D7F31CQ27693849-009DB6F3-FFDC-4748-A425-4E9939E0E11DQ28071559-4C0090D3-9841-4F3A-9999-21C0D2E173F8Q28082836-15724B4B-2C67-45E3-8E34-547F4BC3E8F6Q28256508-E1C1BB26-F564-4C00-A36D-E59AFDBAAFF3Q28554907-3F3213C2-1CB4-48AA-AC30-6D008E772212Q28660329-21F03C57-BD3B-4567-8C27-B34AF2F41440Q30234773-3AF08892-8D55-4996-B076-2D9212281AB2Q30391094-54D774D1-57F8-4DE5-A507-DB6030960636Q30397595-07FF2126-B1B5-4AED-8924-40E68926528CQ33557844-98466DB2-520D-44D2-9513-583C35B455DDQ33577972-B467493D-B9F2-4B8B-BC48-0DF7D9AC40FDQ33592852-ACFE48A0-8B31-44B9-9673-9D9190657CA2Q33594304-AEBD24E6-958E-49BF-A829-E231E928E706Q33612459-B5549175-D146-4766-A350-47D1472F9431Q33759899-12B7D42C-CC0E-4B77-AEB5-A0316CCF8B79Q33772637-A3CA499B-71D1-4129-B221-75CD1CB982E7Q33825684-08125278-1FB3-4945-AC5A-89BDBE705D47Q33946158-8A8C07D3-5C32-4FE7-970D-4857CBCB5735Q33947008-395C8E8F-B1C9-4520-9954-3629A67D4A55Q34016070-9205FA78-FE5E-4131-89DB-C53F06ED0D2CQ34022578-65B257CE-370E-4070-A0CC-E7FD9D90F88FQ34055377-4ED46357-AEBC-4030-9F89-1727612DD86A
P2860
HIV-1 neutralizing antibodies: understanding nature's pathways
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HIV-1 neutralizing antibodies: understanding nature's pathways
@ast
HIV-1 neutralizing antibodies: understanding nature's pathways
@en
HIV-1 neutralizing antibodies: understanding nature's pathways
@nl
type
label
HIV-1 neutralizing antibodies: understanding nature's pathways
@ast
HIV-1 neutralizing antibodies: understanding nature's pathways
@en
HIV-1 neutralizing antibodies: understanding nature's pathways
@nl
prefLabel
HIV-1 neutralizing antibodies: understanding nature's pathways
@ast
HIV-1 neutralizing antibodies: understanding nature's pathways
@en
HIV-1 neutralizing antibodies: understanding nature's pathways
@nl
P2860
P3181
P356
P1476
HIV-1 neutralizing antibodies: understanding nature's pathways
@en
P2860
P304
P3181
P356
10.1111/IMR.12075
P407
P577
2013-07-01T00:00:00Z